CompletedPhase 4

Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

Egypt60 participantsStarted 2019-04-01

Plain-language summary

The aim of this current study is to estimate serum level of YKL-40, serum total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3 months.

Who can participate

Age range30 Years – 70 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diabetic patients with ED. Exclusion Criteria: * Patients with history of pelvic trauma. * Patients with major pelvic surgical intervention. * Patients with hypogonadism and hyperprolactinemia. * Patients with chronic liver disease. * Patients with cardio vascular system diseases. * History of chronic intake of central nervous system, anti androgen drugs or other drugs as Tramadol. * Smokers patients. * Patients with non-vasculogenic Erectile dysfunction.

What they're measuring

Serum YKL-40 and platelets indices in erectile dysfunction

Timeframe: 3 months

Trial details

NCT IDNCT05446493

SponsorAswan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-03-15

View on ClinicalTrials.gov More Erectile Dysfunction trials